News

FDA Approves SKYTROFA® (Lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.